Navigation Links
Merge Healthcare suffers $258M loss in `06

West Allis, Wis. - Acknowledging that a return to profitability won't happen until later this year, Merge Healthcare reported an annual net loss of $258.5 million, or $7.67 per diluted share, in a difficult 2006 that saw several executives resigned in the wake of financial reporting errors.

The loss, which included a goodwill impairment,......

Full article >>> $13.2 million, compared to $25.5 million in the fourth quarter of 2005.


Full article >>>
'"/> By WTN News 03/08/07

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Merge Technologies net loss doubles to $10.1M
3. Merge unveils next-generation imaging-informatics product
4. Merge unveils updated medical imaging software
5. Merge Healthcare unveils diagnostic mammography tool
6. Merge Healthcare promotes Bowers to president
7. Merge Healthcare hires new VP of finance
8. Merge offshoring jobs to "more cost-effective" workforce
9. Merge Healthcare reports $10.8M net loss in Q3
10. Merge eMed releases software upgrade
11. NASDAQ will continue to list Merge
Post Your Comments:

(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)...  The Biodesign Challenge (BDC), a university competition that ... living systems and biotechnology, announced its winning teams at ... New York City . The teams, ... at MoMA,s Celeste Bartos Theater during the daylong summit. ... curator of architecture and design, and Suzanne Lee ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
(Date:5/20/2016)... 20, 2016  VoiceIt is excited to announce ... By working together, VoiceIt and VoicePass ... and VoicePass take slightly different approaches to voice ... security and usability. ... new partnership. "This marketing and technology ...
(Date:4/28/2016)... and BANGALORE, India , April 28, ... Systems, a product subsidiary of Infosys (NYSE: INFY ... announced a global partnership that will provide end ... use mobile banking and payment services.      (Logo: ... key innovation area for financial services, but it also plays ...
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
Breaking Biology News(10 mins):